Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/130149
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Sclerostin directly stimulates osteocyte aynthesis of fibroblast growth factor-23
Author: Ito, N.
Prideaux, M.
Wijenayaka, A.R.
Yang, D.
Ormsby, R.T.
Bonewald, L.F.
Atkins, G.J.
Citation: Calcified Tissue International, 2021; 109(1):66-76
Publisher: Springer
Issue Date: 2021
ISSN: 0171-967X
1432-0827
Statement of
Responsibility: 
Nobuaki Ito, Matthew Prideaux, Asiri R. Wijenayaka, Dongqing Yang, Renee T. Ormsby, Lynda F. Bonewald, Gerald J. Atkins
Abstract: Osteocyte produced fibroblast growth factor 23 (FGF23) is the key regulator of serum phosphate (Pi) homeostasis. The interplay between parathyroid hormone (PTH), FGF23 and other proteins that regulate FGF23 production and serum Pi levels is complex and incompletely characterised. Evidence suggests that the protein product of the SOST gene, sclerostin (SCL), also a PTH target and also produced by osteocytes, plays a role in FGF23 expression, however the mechanism for this effect is unclear. Part of the problem of understanding the interplay of these mediators is the complex multi-organ system that achieves Pi homeostasis in vivo. In the current study, we sought to address this using a cell line model of the osteocyte, IDG-SW3, known to express FGF23 at both the mRNA and protein levels. In cultures of differentiated IDG-SW3 cells, both PTH(1-34) and recombinant human (rh) SCL remarkably induced Fgf23 mRNA expression dose-dependently within 3 h. Both rhPTH(1-34) and rhSCL also strongly induced C-terminal FGF23 protein secretion. Secreted intact FGF23 levels remained unchanged, consistent with constitutive post-translational cleavage of FGF23 in this cell model. Both rhPTH(1-34) and rhSCL treatments significantly suppressed mRNA levels of Phex, Dmp1 and Enpp1 mRNA, encoding putative negative regulators of FGF23 levels, and induced Galnt3 mRNA expression, encoding N-acetylgalactosaminyl-transferase 3 (GalNAc-T3), which protects FGF23 from furin-like proprotein convertase-mediated cleavage. The effect of both rhPTH(1-34) and rhSCL was antagonised by pre-treatment with the NF-κβ signalling inhibitors, BAY11 and TPCK. RhSCL also stimulated FGF23 mRNA expression in ex vivo cultures of human bone. These findings provide evidence for the direct regulation of FGF23 expression by sclerostin. Locally expressed sclerostin via the induction of FGF23 in osteocytes thus has the potential to contribute to the regulation of Pi homeostasis.
Keywords: FGF23; PTH; sclerostin; SOST; IDG-SW3; phosphate homeostasis
Description: Published online: 22 February 2021
Rights: © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021
DOI: 10.1007/s00223-021-00823-6
Grant ID: http://purl.org/au-research/grants/nhmrc/1047796
http://purl.org/au-research/grants/nhmrc/1080806
http://purl.org/au-research/grants/nhmrc/1106029
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.